Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Opposing functions of F-BAR proteins in neuronal membrane protrusion, tubule formation, and neurite outgrowth.

Taylor KL, Taylor RJ, Richters KE, Huynh B, Carrington J, McDermott ME, Wilson RL, Dent EW.

Life Sci Alliance. 2019 Jun 3;2(3). pii: e201800288. doi: 10.26508/lsa.201800288. Print 2019 Jun.

2.

Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial.

Taylor KL, Deros DE, Fallon S, Stephens J, Kim E, Lobo T, Davis KM, Luta G, Jayasekera J, Meza R, Stanton CA, Niaura RS, Abrams DB, McKee B, Howell J, Ramsaier M, Batlle J, Dornelas E, Parikh V, Anderson E.

Contemp Clin Trials. 2019 May 23;82:25-35. doi: 10.1016/j.cct.2019.05.006. [Epub ahead of print]

PMID:
31129371
3.

Author Correction: CasX enzymes comprise a distinct family of RNA-guided genome editors.

Liu JJ, Orlova N, Oakes BL, Ma E, Spinner HB, Baney KLM, Chuck J, Tan D, Knott GJ, Harrington LB, Al-Shayeb B, Wagner A, Brötzmann J, Staahl BT, Taylor KL, Desmarais J, Nogales E, Doudna JA.

Nature. 2019 Apr;568(7752):E8-E10. doi: 10.1038/s41586-019-1084-8.

PMID:
30944483
4.
5.

Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification.

Neate SL, Taylor KL, Jelinek GA, De Livera AM, Brown CR, Weiland TJ.

PLoS One. 2019 Feb 28;14(2):e0212422. doi: 10.1371/journal.pone.0212422. eCollection 2019.

6.

Associations of demographic and clinical factors with depression over 2.5-years in an international prospective cohort of people living with MS.

Simpson S Jr, Taylor KL, Jelinek GA, De Livera AM, Brown CR, O'Kearney E, Neate SL, Bevens W, Weiland TJ.

Mult Scler Relat Disord. 2019 May;30:165-175. doi: 10.1016/j.msard.2019.02.014. Epub 2019 Feb 11.

7.

Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life.

Phyo AZZ, Jelinek GA, Brown CR, O'Kearney E, Neate SL, De Livera AM, Taylor KL, Bevens W, Simpson S Jr, Weiland TJ.

Mult Scler Relat Disord. 2019 May;30:25-32. doi: 10.1016/j.msard.2019.01.037. Epub 2019 Jan 24.

8.

CasX enzymes comprise a distinct family of RNA-guided genome editors.

Liu JJ, Orlova N, Oakes BL, Ma E, Spinner HB, Baney KLM, Chuck J, Tan D, Knott GJ, Harrington LB, Al-Shayeb B, Wagner A, Brötzmann J, Staahl BT, Taylor KL, Desmarais J, Nogales E, Doudna JA.

Nature. 2019 Feb;566(7743):218-223. doi: 10.1038/s41586-019-0908-x. Epub 2019 Feb 4. Erratum in: Nature. 2019 Apr;568(7752):E8-E10.

PMID:
30718774
9.

CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification.

Oakes BL, Fellmann C, Rishi H, Taylor KL, Ren SM, Nadler DC, Yokoo R, Arkin AP, Doudna JA, Savage DF.

Cell. 2019 Jan 10;176(1-2):254-267.e16. doi: 10.1016/j.cell.2018.11.052.

PMID:
30633905
10.

Health Outcomes and Lifestyle in a Sample of People With Multiple Sclerosis (HOLISM): Longitudinal and Validation Cohorts.

Weiland TJ, De Livera AM, Brown CR, Jelinek GA, Aitken Z, Simpson SL Jr, Neate SL, Taylor KL, O'Kearney E, Bevens W, Marck CH.

Front Neurol. 2018 Dec 12;9:1074. doi: 10.3389/fneur.2018.01074. eCollection 2018.

11.

Longitudinal Associations of the Healthy Lifestyle Index Score With Quality of Life in People With Multiple Sclerosis: A Prospective Cohort Study.

Leong TI, Weiland TJ, Jelinek GA, Simpson S, Brown CR, Neate SL, Taylor KL, O'Kearney E, Milanzi E, De Livera AM.

Front Neurol. 2018 Nov 2;9:874. doi: 10.3389/fneur.2018.00874. eCollection 2018.

12.

Longitudinal Associations of Modifiable Lifestyle Factors With Positive Depression-Screen Over 2.5-Years in an International Cohort of People Living With Multiple Sclerosis.

Taylor KL, Simpson S Jr, Jelinek GA, Neate SL, De Livera AM, Brown CR, O'Kearney E, Marck CH, Weiland TJ.

Front Psychiatry. 2018 Oct 30;9:526. doi: 10.3389/fpsyt.2018.00526. eCollection 2018.

13.

Self-reported cognitive function in a large international cohort of people with multiple sclerosis: associations with lifestyle and other factors.

Jelinek PL, Simpson S Jr, Brown CR, Jelinek GA, Marck CH, De Livera AM, O'Kearney E, Taylor KL, Neate SL, Weiland TJ.

Eur J Neurol. 2019 Jan;26(1):142-154. doi: 10.1111/ene.13784. Epub 2018 Sep 14.

PMID:
30133057
14.

Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives.

O'Neill SC, Taylor KL, Clapp J, Jayasekera J, Isaacs C, Mary Atieh Graham D, Goldberg SL, Mandelblatt J.

J Health Commun. 2018;23(7):679-686. doi: 10.1080/10810730.2018.1506836. Epub 2018 Aug 21.

PMID:
30130477
15.

Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up.

Marck CH, De Livera AM, Brown CR, Neate SL, Taylor KL, Weiland TJ, Hadgkiss EJ, Jelinek GA.

PLoS One. 2018 May 23;13(5):e0197759. doi: 10.1371/journal.pone.0197759. eCollection 2018.

16.

The Efficacy of Psychological Interventions for Managing Fatigue in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Phyo AZZ, Demaneuf T, De Livera AM, Jelinek GA, Brown CR, Marck CH, Neate SL, Taylor KL, Mills T, O'Kearney E, Karahalios A, Weiland TJ.

Front Neurol. 2018 Apr 4;9:149. doi: 10.3389/fneur.2018.00149. eCollection 2018.

17.

Exercise testing protocol using a roller system for manual wheelchair users with spinal cord injury.

Morgan KA, Taylor KL, Tucker SM, Cade WT, Klaesner JW.

J Spinal Cord Med. 2019 May;42(3):288-297. doi: 10.1080/10790268.2018.1443542. Epub 2018 Mar 8.

PMID:
29517419
18.

Validity and Reliability of the Load-Velocity Relationship to Predict the One-Repetition Maximum in Deadlift.

Ruf L, Chéry C, Taylor KL.

J Strength Cond Res. 2018 Mar;32(3):681-689. doi: 10.1519/JSC.0000000000002369.

PMID:
29466270
19.

Psychological Shift in Partners of People with Multiple Sclerosis Who Undertake Lifestyle Modification: An Interpretive Phenomenological Study.

Neate SL, Taylor KL, Jelinek GA, De Livera AM, Brown CR, Weiland TJ.

Front Psychol. 2018 Jan 31;9:15. doi: 10.3389/fpsyg.2018.00015. eCollection 2018.

20.

Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.

Taylor KL, Luta G, Hoffman RM, Davis KM, Lobo T, Zhou Y, Leimpeter A, Shan J, Jensen RE, Aaronson DS, Van Den Eeden SK.

Transl Behav Med. 2018 Mar 1;8(2):156-165. doi: 10.1093/tbm/ibx005.

21.

A Publicly Available Landscape Analysis Tool for Biodefense Policy.

Omberg KM, Franklin LR, Jackson DR, Taylor KL, Wahl KL, Lesperance A, Wynkoop EM, Gray JAS, Leiser OP, Frazar SL, Ozanich R, Bartholomew R.

Health Secur. 2018 Jan/Feb;16(1):77-78. doi: 10.1089/hs.2017.0088. Epub 2018 Jan 19. No abstract available.

22.

Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration.

Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, Fu SS, Graham AL, Lindgren BR, Melzer AC, Ostroff JS, Seaman EL, Taylor KL, Toll BA, Zeliadt SB, Vock DM.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):172-182. doi: 10.1164/rccm.201705-0909CI. Review.

23.

Pain in People with Multiple Sclerosis: Associations with Modifiable Lifestyle Factors, Fatigue, Depression, Anxiety, and Mental Health Quality of Life.

Marck CH, De Livera AM, Weiland TJ, Jelinek PL, Neate SL, Brown CR, Taylor KL, Khan F, Jelinek GA.

Front Neurol. 2017 Sep 5;8:461. doi: 10.3389/fneur.2017.00461. eCollection 2017.

24.

Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening.

Taghizadeh N, Taylor KL, MacEachern P, Koetzler R, Dickinson JA, Gillson A, Yang H, Tammemagi MC, Penz E, Pendharkar SR, Lam SC, Graham A, Culling J, Burrowes P, Bédard ELR, Tremblay A.

Lung Cancer. 2017 Sep;111:101-107. doi: 10.1016/j.lungcan.2017.07.017. Epub 2017 Jul 19.

PMID:
28838378
25.

Utilization and predictors of expectant management among elderly men with low-and intermediate-risk localized prostate cancer in U.S. urological practice.

Tsai HT, Philips G, Taylor KL, Kowalczyk K, Huai-Ching K, Potosky AL.

Urol Pract. 2017 Mar;4(2):132-139. doi: 10.1016/j.urpr.2016.05.005.

26.

International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey.

Reilly GD, Mahkawnghta AS, Jelinek PL, De Livera AM, Weiland TJ, Brown CR, Taylor KL, Neate SL, Jelinek GA, Marck CH.

Front Neurol. 2017 May 31;8:229. doi: 10.3389/fneur.2017.00229. eCollection 2017.

27.

Decision-making processes among men with low-risk prostate cancer: A survey study.

Hoffman RM, Van Den Eeden SK, Davis KM, Lobo T, Luta G, Shan J, Aaronson D, Penson DF, Leimpeter AD, Taylor KL.

Psychooncology. 2018 Jan;27(1):325-332. doi: 10.1002/pon.4469. Epub 2017 Jul 13.

28.

Physicians' perspectives on the informational needs of low-risk prostate cancer patients.

Hagerman CJ, Bellini PG, Davis KM, Hoffman RM, Aaronson DS, Leigh DY, Zinar RE, Penson D, Van Den Eeden S, Taylor KL.

Health Educ Res. 2017 Apr 1;32(2):134-152. doi: 10.1093/her/cyx035.

29.

The Effect of Initial Knee Angle on Concentric-Only Squat Jump Performance.

Mitchell LJ, Argus CK, Taylor KL, Sheppard JM, Chapman DW.

Res Q Exerc Sport. 2017 Jun;88(2):184-192. doi: 10.1080/02701367.2017.1293777. Epub 2017 Mar 24.

PMID:
28339350
30.

Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.

Taylor KL, Hagerman CJ, Luta G, Bellini PG, Stanton C, Abrams DB, Kramer JA, Anderson E, Regis S, McKee A, McKee B, Niaura R, Harper H, Ramsaier M.

Lung Cancer. 2017 Jun;108:242-246. doi: 10.1016/j.lungcan.2017.01.020. Epub 2017 Feb 15.

31.

Paravertebral block in paediatric abdominal surgery-a systematic review and meta-analysis of randomized trials.

Page EA, Taylor KL.

Br J Anaesth. 2017 Feb;118(2):159-166. doi: 10.1093/bja/aew387. Review.

32.

A description of the "event manager" role in resuscitations: A qualitative study of interviews and focus groups of resuscitation participants.

Taylor KL, Parshuram CS, Ferri S, Mema B.

J Crit Care. 2017 Jun;39:254-258. doi: 10.1016/j.jcrc.2016.12.015. Epub 2016 Dec 27.

PMID:
28082053
33.

Lifestyle, medication and socio-demographic determinants of mental and physical health-related quality of life in people with multiple sclerosis.

Jelinek GA, De Livera AM, Marck CH, Brown CR, Neate SL, Taylor KL, Weiland TJ.

BMC Neurol. 2016 Nov 22;16(1):235.

34.

Mechanically assisted bidirectional cavopulmonary shunt in neonates and infants: An acute human pilot study.

Honjo O, Merklinger SL, Poe JB, Guerguerian AM, Zhang H, Taylor KL, Van Arsdell GS.

J Thorac Cardiovasc Surg. 2017 Feb;153(2):441-447. doi: 10.1016/j.jtcvs.2016.09.048. Epub 2016 Sep 28.

35.

Sexual function in multiple sclerosis and associations with demographic, disease and lifestyle characteristics: an international cross-sectional study.

Marck CH, Jelinek PL, Weiland TJ, Hocking JS, De Livera AM, Taylor KL, Neate SL, Pereira NG, Jelinek GA.

BMC Neurol. 2016 Nov 4;16(1):210.

36.

Breast Cancer Screening Among Korean Americans: A Systematic Review.

Oh KM, Taylor KL, Jacobsen KH.

J Community Health. 2017 Apr;42(2):324-332. doi: 10.1007/s10900-016-0258-7. Review.

PMID:
27678390
37.

Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.

Jelinek GA, De Livera AM, Marck CH, Brown CR, Neate SL, Taylor KL, Weiland TJ.

PLoS One. 2016 Aug 25;11(8):e0161701. doi: 10.1371/journal.pone.0161701. eCollection 2016.

38.

Cross-species prediction of human survival probabilities for accelerated anthrax vaccine absorbed (AVA) regimens and the potential for vaccine and antibiotic dose sparing.

Stark GV, Sivko GS, VanRaden M, Schiffer J, Taylor KL, Hewitt JA, Quinn CP, Nuzum EO.

Vaccine. 2016 Dec 12;34(51):6512-6517. doi: 10.1016/j.vaccine.2016.06.041. Epub 2016 Aug 22.

39.

Patient Perspectives on Low-Dose Computed Tomography for Lung Cancer Screening, New Mexico, 2014.

Mishra SI, Sussman AL, Murrietta AM, Getrich CM, Rhyne R, Crowell RE, Taylor KL, Reifler EJ, Wescott PH, Saeed AI, Hoffman RM.

Prev Chronic Dis. 2016 Aug 18;13:E108. doi: 10.5888/pcd13.160093.

40.

Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

Taylor KL, Hoffman RM, Davis KM, Luta G, Leimpeter A, Lobo T, Kelly SP, Shan J, Aaronson D, Tomko CA, Starosta AJ, Hagerman CJ, Van Den Eeden SK.

Cancer Epidemiol Biomarkers Prev. 2016 Aug;25(8):1240-50. doi: 10.1158/1055-9965.EPI-15-1079. Epub 2016 Jun 2.

41.

Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.

Sivko GS, Stark GV, Tordoff KP, Taylor KL, Glaze E, VanRaden M, Schiffer JM, Hewitt JA, Quinn CP, Nuzum EO.

Vaccine. 2016 Dec 12;34(51):6518-6528. doi: 10.1016/j.vaccine.2016.04.048. Epub 2016 May 4.

42.

Beyond the cytoskeleton: The emerging role of organelles and membrane remodeling in the regulation of axon collateral branches.

Winkle CC, Taylor KL, Dent EW, Gallo G, Greif KF, Gupton SL.

Dev Neurobiol. 2016 Dec;76(12):1293-1307. doi: 10.1002/dneu.22398. Epub 2016 May 9. Review.

43.

Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management.

Kelly SP, Van Den Eeden SK, Hoffman RM, Aaronson DS, Lobo T, Luta G, Leimpter AD, Shan J, Potosky AL, Taylor KL.

J Urol. 2016 Sep;196(3):734-40. doi: 10.1016/j.juro.2016.04.045. Epub 2016 Apr 14.

44.

CBT-I Coach: A Description and Clinician Perceptions of a Mobile App for Cognitive Behavioral Therapy for Insomnia.

Kuhn E, Weiss BJ, Taylor KL, Hoffman JE, Ramsey KM, Manber R, Gehrman P, Crowley JJ, Ruzek JI, Trockel M.

J Clin Sleep Med. 2016 Apr 15;12(4):597-606. doi: 10.5664/jcsm.5700.

45.

Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.

Marck CH, Neate SL, Taylor KL, Weiland TJ, Jelinek GA.

PLoS One. 2016 Feb 5;11(2):e0148573. doi: 10.1371/journal.pone.0148573. eCollection 2016.

46.

Incorporating a Smoking Cessation Intervention into Lung Cancer Screening Programs: Preliminary Studies.

Hagerman CJ, Tomko CA, Stanton CA, Kramer JA, Abrams DB, Anderson ED, Taylor KL.

J Psychosoc Oncol. 2015;33(6):703-23. doi: 10.1080/07347332.2015.1082171.

47.

BAR-SH3 sorting nexins are conserved interacting proteins of Nervous wreck that organize synapses and promote neurotransmission.

Ukken FP, Bruckner JJ, Weir KL, Hope SJ, Sison SL, Birschbach RM, Hicks L, Taylor KL, Dent EW, Gonsalvez GB, O'Connor-Giles KM.

J Cell Sci. 2016 Jan 1;129(1):166-77. doi: 10.1242/jcs.178699. Epub 2015 Nov 13.

48.

Time Course of Improvements in Power Characteristics in Elite Development Netball Players Entering a Full-Time Training Program.

McKeown I, Chapman DW, Taylor KL, Ball NB.

J Strength Cond Res. 2016 May;30(5):1308-15. doi: 10.1519/JSC.0000000000001212.

PMID:
26439781
49.

The Influence of Training Phase on Error of Measurement in Jump Performance.

Taylor KL, Hopkins WG, Chapman DW, Cronin JB.

Int J Sports Physiol Perform. 2016 Mar;11(2):235-9. doi: 10.1123/ijspp.2015-0115. Epub 2015 Jul 13.

PMID:
26181005
50.

Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography.

Hoffman RM, Sussman AL, Getrich CM, Rhyne RL, Crowell RE, Taylor KL, Reifler EJ, Wescott PH, Murrietta AM, Saeed AI, Mishra SI.

Prev Chronic Dis. 2015 Jul 9;12:E108. doi: 10.5888/pcd12.150112.

Supplemental Content

Loading ...
Support Center